Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT07019155Recruiting
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Acute Myeloid LeukemiaGermline MutationMyelodysplastic Syndromes
PrincipalinvestigatorStart date: 2025-07-24
NCT04339777Phase 2Recruiting
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Autoimmune LymphoproliferativeCommon Variable ImmunodeficiencyImmune System Diseases+2 more
PrincipalinvestigatorStart date: 2020-09-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLymphoproliferative Disorders

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Immune System DiseasesLeukemia, Myeloid, AcuteMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score8%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score8%

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Immune System DiseasesMyelodysplastic Syndromes
Similarity Score8%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Richard W Childs, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07019155PrincipalInvestigator

Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

Acute Myeloid LeukemiaGermline MutationMyelodysplastic Syndromes
Recruiting
NCT04339777Phase 2PrincipalInvestigator

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Autoimmune LymphoproliferativeCommon Variable ImmunodeficiencyImmune System Diseases+2 more
Recruiting

All 2 trials loaded